You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Peculiarities of combination of the postviral fatigue syndrome and posttraumatic stress disorder (lecture)

ISSN 2223-6775 Ukrainian journal of occupational health Vol.16, No 4, 2020

Peculiarities of combination of the postviral fatigue syndrome and posttraumatic stress disorder (lecture)

Zaitsev D.V., Alekseieva L.M., Opanasenko V.V.

State institution «Kundiiev Institute of Occupational Health of the National Academy of Medical Sciences of Ukraine», Kyiv

Full article (PDF), UKR

Introduction. Posttraumatic stress disorder (PTSD) and postviral fatigue syndrome (PFS) were nosologically defined several decades ago and need for futher study. Both syndromes belong to the group of adjustment disorders and have similar features in pathogenesis and clinic. In Ukraine, the problem of PTSD has become relevant since 2014 through the hostilities in the east of the country; at the same time, insufficient attention is paid to the problem of PFS and especially to the comorbidity of PFS and PTSD.

Aim. Review and analyze of the comorbidity of PTSD and PFS in combatants.

Methods. We selected literary data in the search engines Google Scholar, PubMed and sources of clinical guidelines recommended by the Order of the Ministry of Health of Ukraine No. 1422 (2016) for the keywords "chronic fatigue syndrome", "post-traumatic stress disorder", "military personnel" (Ukrainian, Russian and English) for the period of 2000-2020.

Results. The prevalence of PTSD and PFS is estimated roughly; in Ukraine, we suspect insufficient identification of such disorders. For combatants, the tension of adaptation mechanisms persists throughout their stay in the conflict zone. Risk factors for the development of PTSD and PFS in combatants are individual and situational. The pathogenesis of PFS and PTSD has similar features. The clinical manifestations of PFS attract attention when they are significant, while in PTSD the symptoms rapidly progress and are quite clear. Diagnosis of PTSD passes a well-established algorithm, while the diagnosis of PFS is less defined and is based on some number of controversial diagnostic criteria. The tactics of therapy and rehabilitation are supportive and symptomatic. In PTSD, preference is given to psychotherapy and pharmacotherapy with selective serotonin reuptake inhibitors. For PFS, specific pharmacotherapy has been proposed for variants associated with herpesvirus infection only.

Conclusion. Considering PTSD and PFS as maladaptosis caused, by superintense and superlonged stressors, respectively, it is clinically advisable to take into account their pathogenetic relationship. The comorbidity of PTSD and PFS in combatants requires further study, in particular, from the standpoint of psychophysiology.

Key words: chronic fatigue syndrome, post-traumatic stress disorder, combatants.


  1. Vanyukhina N.V., Grigorieva O.V., Probochkin E.Yu. (2018), “Mental states of communication engineers with various professional responsibilities”, Materials of the Third International Scientific Conference "Psychology of Human Conditions: Topical Theoretical and Applied Problems". Kazan, November 8-10, 2018.S. 98-101.
  2. Vyazmitinova S.A. (2018), “Adaptation disorders and their psychotherapeutic correction in combatants”, Medychna psykhologia, 63-67.
  3. Kokun OM. (2014), “Peculiarities of negative mental states in the services”, Visnyk Natsionalʹnoho universytetu oborony Ukrayiny.42 (5), 185-190.
  4. Maltsev DV, Nedopako Ya.Ya., Hrytsyk VF et al. (2015), “Temporal median sclerosis”, Ukrayinsʹkyy nevrolohichnyy zhurnal, 4,7-20.
  5. Napryeyenko O.K., Syropyatov O.H., Druzʹ O.V. (2014), Psykholoho-psykhiatrychna dopomoha postrazhdalym u zbroynykh konfliktakh : metod. rek. [Psychological and psychiatric care for victims of armed conflicts, methodical recommendations], Kyiv, Ukraine.
  6. Petrova EV, Semenova NV, Alekhin AN. (2011), “Regularities of development and features of the emotional burnout syndrome in doctors and nurses of psychiatric institutions”, Vestnik Tomskogo gosudarstvennogo pedagogicheskogo universiteta,12, 194-199.
  7. Taranova O.V. (2014), “Emotional burnout syndrome, chronic fatigue syndrome and factors of professional success (on the example of driving teachers), Abstract of dissert., psychol. Sciences, Russian State University for the Humanities", Moscow, Russia.
  8. Tkachenko A.V., Danilchuk K.A. (2010), “The effect of magnesium and calcium on human health and their content in food”, in Conference "Problems and prospects of scientific research", Krasnodar, 199-202.
  9. Tsygan V.N. (2010), “Chronic fatigue syndrome and its correction with cortexin”, Rossiyskiy meditsinskiy zhurnal,18 (16), 1004-1007.
  10. Agmon-Levin N., Zafrir Y., Kivity S. et al. (2014), “Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the ‘autoimmune (auto-inflammatory) syndrome induced by adjuvants’ (ASIA)”, Res., 60 (2-3),376-383.
  11. Aoki R., Kobayashi N., Suzuki G. et al.(2016), “Human herpesvirus 6 and 7 are biomarkers for fatigue, which distinguish between physiological fatigue and pathological fatigue”, Biophys. Res. Commun., 478(1), 424-430.
  12. Brenu E.W., Huth T.K., Hardcastle S.L. et al. (2014), “Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis”, Int Immunol., 26 (4), 233-42.
  13. Carruthers B.M. at al.(2011), “Myalgic encephalomyelitis: International consensus criteria”, Journal of International Medicine, Journal of Internal Medicine, 270, 4, 327-338.
  14. Cohn M., St-Laurent M., Barnett A., McAndrews M.P. (2015), “Social inference deficits in temporal lobe epilepsy and lobectomy: risk factors and neural substrates”, Cogn. Affect Neurosci., 10 (5), 636-644.
  15. De Oliveira G.N., Kummer A., Salgado J.V. et al. (2010), “Psychiatric disorders in temporal lobe epilepsy: an overview from a tertiary service in Brazil”, Seizure, 19 (8), 479-484.
  16. Goldstein R.B., Smith S.M., Chou S.P. et al. (2016), “The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III”, Soc Psychiatry Psychiatr Epidemiol, 51,1137.
  17. Gradus J.L., Farkas D.K., Svensson E. et al. (2015), “Posttraumatic stress disorder and cancer risk: a nationwide cohort study”, Eur J Epidemiol, 30, 563.
  18. Greenberg M.S., Tanev K., Marin M.F., Pitman R.K. (2014), “Stress, PTSD, and dementia”, Alzheimers Dement, 10, 155.
  19. Hoge C.W., McGurk D., Thomas J.L. et al. (2008), “Mild traumatic brain injury in U.S. soldiers returning from Iraq”, N Engl J Med, 358, 453.
  20. Howard J.T., Sosnov J.A., Janak J.C. et al. (2018), “Associations of initial injury severity and posttraumatic stress disorder diagnoses with long-term hypertension risk after combat injury”, Hypertension, 71,824.
  21. Jak A.J., Jurick S., Crocker L.D. et al. (2019), “SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial”, J Neurol Neurosurg Psychiatry, 90, 333.
  22. Karl A., Schaefer M., Malta L.S. et al. (2006), “A meta-analysis of structural brain abnormalities in PTSD”, Neurosci Biobehav Rev, 30, 1004.
  23. Kessler R.C., Rose S., Koenen K.C. et al. (2014), “How well can post-traumatic stress disorder be predicted from pre-trauma risk factors? An exploratory study in the WHO World Mental Health Surveys”, World Psychiatry, 13, 265.
  24. Koenen K.C., Ratanatharathorn A., Ng L. et al. (2017), “Posttraumatic stress disorder in the World Mental Health Surveys”, Psychol Med, 47, 2260.
  25. Krystal J.H., Rosenheck R.A., Cramer J.A. et al. (2011), “Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial”, JAMA, 306, 493.
  26. Leeies M., Pagura J., Sareen J., Bolton J.M. (2010), “The use of alcohol and drugs to self-medicate symptoms of posttraumatic stress disorder”, Depress Anxiety, 27, 731.
  27. Lohr J.B., Palmer B.W., Eidt C.A. et al. (2015), Is Post-Traumatic Stress Disorder Associated with Premature Senescence. A Review of the Literature”, Am J Geriatr Psychiatry, 23, 709.
  28. Markowitz A.J., Rabow M.W. (2007), “Palliative management of fatigue at the close of life: "it feels like my body is just worn out", JAMA, 298, 217.
  29. Markowitz J.C., Petkova E., Neria Y. et al. (2015), “Is Exposure Necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD”, Am J Psychiatry, 172, 430.
  30. Masuda A., Nakayama T., Yamanaka T. et al. (2002), “The prognosis after multidisciplinary treatment for patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome”, Behav. Med., 25 (5), 487-497.
  31. O'Donovan A., Cohen B.E., Seal K.H. et al. (2015), “Elevated risk for autoimmune disorders in iraq and afghanistan veterans with posttraumatic stress disorder”, Biol Psychiatry, 77, 365.
  32. Pagura J., Stein M.B., Bolton J.M. et al. (2010), “Comorbidity of borderline personality disorder and posttraumatic stress disorder in the U.S. population”, J Psychiatr Res, 44,1190.
  33. Parker A.M., Sricharoenchai T., Raparla S. et al. (2015), “Posttraumatic stress disorder in critical illness survivors: a metaanalysis”, Crit Care Med, 43, 1121.
  34. Patten S.B. (2016), “Mental health in the Canadian Armed Forces: new data, new answers, and new questions”, Can J Psychiatry, 61, 4S.
  35. Raskind M.A., Peskind E.R., Chow B. et al. (2018), “Trial of prazosin for post-traumatic stress disorder in military veterans”, N Engl J Med, 378. 507.
  36. Resick P.A., Galovski T.E., O'Brien Uhlmansiek M. et al. (2008), “A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence”, J Consult Clin Psychol, 76, 243.
  37. Spoont M.R., Williams J.W. Jr, Kehle-Forbes S. et al. (2015), “Does this patient have posttraumatic stress disorder? Rational clinical examination systematic review”, JAMA, 314, 501.
  38. Stein D.J., Ipser J.C., Seedat S. (2006), “Pharmacotherapy for post traumatic stress disorder (PTSD)”, Cochrane Database Syst Rev, CD002795.
  39. Stein M.B., Kessler R.C., Heeringa S.G. et al. (2015), “Prospective longitudinal evaluation of the effect of deployment-acquired traumatic brain injury on posttraumatic stress and related disorders: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS)”, Am J Psychiatry, 172, 1101.
  40. Wilson J.F. (2007), “Posttraumatic stress disorder needs to be recognized in primary care”, Ann Intern Med, 146, 617.